Health Condition 1: null- difficulty in breathing, cough, wheezing and chest tightness
Conditions
Interventions
Intervention1: Group A: Treated with Agatyaharitaki Avaleha 6 gram of the drug twice a daily for 60 days before meal
Control Intervention1: Group B: Treated with Agastyaharitaki granules 6 gram of the
Sponsors
Institute For Post Gradute Teaching and Research in Ayurveda Gujrat Ayurved University
Eligibility
Inclusion criteria
Inclusion criteria: 1. Mild persistent cases of Bronchial Asthma with day time symptoms 3-6/week and nocturnal symptoms with 3-4/month. 2. Moderate persistence cases with daytime symptoms daily and nocturnal symptoms with one or more than one week but not more than 2 weeks.
Exclusion criteria
Exclusion criteria: 1. Known patients of diabetes mellitus and uncontrolled HTN. 2. Dyspnoea resulting from cardiac origin, other lung pathologies (like-lower respiratory tract infection,Chronic obstructive pulmonary disease, Emphysema, upper respiratory tract obstruction, bronchiectasis,interstitial lung disease, occupational lung disease,tropical pulmonary eosinophilia,Tuberculosis, Pulmonary malignancy, chronic pluritis, plural effusion),anaemia. 3. Age above 60 years and below 16 years. Pregnant and lactating mothers. Patients suffering with other types of Shwasa,i.e. Maha, Urdha, ChhinnaShwasa will be excluded from the study. 4. Febrile patients on presentation or history of fever within past one week.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| It is expected that the trial drugs will exert a significant action over Tamaka Shwasa (Bronchial Asthma)Timepoint: 2 month | — |
Secondary
| Measure | Time frame |
|---|---|
| significant relief in the sign and symptoms of tamaka shwasa (bronchial asthama)Timepoint: 2 month | — |
Countries
India
Contacts
Public ContactVasundhra Jaluthriya
IPGT and RA
Outcome results
None listed